• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ren Fail . Trajectory of AKI and hospital mortality among patients with COVID-19

tetano

Editor, Senior Moderator
Ren Fail


. 2023 Dec;45(1):2177086.
doi: 10.1080/0886022X.2023.2177086.
Trajectory of AKI and hospital mortality among patients with COVID-19


Seong Geun Kim[SUP] 1 2 [/SUP], Chung Hee Han[SUP] 3 [/SUP], Sung Bong Yu[SUP] 4 [/SUP], Hyeseung Lee[SUP] 2 [/SUP], Soie Kwon[SUP] 1 2 [/SUP], Yerim Kim[SUP] 5 [/SUP], Jeonghwan Lee[SUP] 1 6 [/SUP], Dong Ki Kim[SUP] 1 2 [/SUP], Yun Kyu Oh[SUP] 1 6 [/SUP], Chun Soo Lim[SUP] 1 6 [/SUP], Yon Su Kim[SUP] 1 2 [/SUP], Byung Gun Kim[SUP] 7 [/SUP], Jung Pyo Lee[SUP] 1 6 [/SUP]



Affiliations

Abstract

Background: Acute kidney injury (AKI) in COVID-19 patients is associated with poor prognosis. Characterization of AKI by timing and trajectory and early prediction of AKI progression is required for better preventive management and the prediction of patient outcomes.
Methods: A total of 858 patients who were hospitalized due to coronavirus disease 2019 (COVID-19) were retrospectively enrolled from December 2020 to August 2021. The occurrence of AKI was evaluated throughout hospitalization. The hazard ratios (HRs) of mortality outcomes according to the trajectory of AKI were measured using Cox regression models after adjustment for multiple variables.
Results: Among 858 patients, 226 (26.3%) presented AKI at admission, and 44 (5.1%) developed AKI during hospitalization. Patients with AKI at admission or hospital-acquired AKI had a higher risk of mortality than those without AKI, with HRs of 9.87 (2.81-34.67) and 13.74 (3.57-52.84), respectively. Of 226 patients with AKI at admission, 104 (46.0%) recovered within 48 hr, 83 (36.7%) had AKI beyond 48 hr and recovered in 7 days, and 39 (17.3%) showed no recovery from AKI on Day 7. Delayed recovery and persistent AKI were significantly associated with an increased risk of mortality, with HRs of 4.39 (1.06-18.24) and 24.33 (7.10-83.36), respectively.
Conclusions: The onset and progression of AKI was significantly associated with in-hospital mortality in patients with COVID-19. A thorough observation of the recovery trajectory of early AKI after infection is necessary.

Keywords: Acute kidney injury; COVID-19; mortality; renal recovery.
 
Back
Top Bottom